ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results : vimarsana.com

PLEASANTON, Calif., March 26, 2024 -- ProSomnus, Inc. , the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea , today announced financial results for the fourth quarter and...

Related Keywords

United States , Len Liptak , Mike Cavanaugh , Heather Whalen , Drug Administration , Nasdaq , Exchange Commission , Securities Exchange , Prosomnus Inc , Company Next Generation Remote Patient Monitoring , Obstructive Sleep Apnea , Next Generation Remote Patient Monitoring , Premarket Notification , Chief Executive , Severe Obstructive Sleep Apnea , Obstructive Sleep , Fourth Quarter , Year Ended December , Front Line , Investor Relations , Press Release , Securities Act , Securities Exchange Act , Annual Report , Convertible Notes , Markets ,